Skip to main content

MDMA

ADVERTISEMENT
Identification
Molecular formula
C11H15NO2
CAS number
42542-10-9
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-methyl-propan-2-amine
State
State

At room temperature, MDMA is typically found as a crystalline solid or as a powder.

Melting point (Celsius)
148.81
Melting point (Kelvin)
421.96
Boiling point (Celsius)
100.10
Boiling point (Kelvin)
373.25
General information
Molecular weight
193.25g/mol
Molar mass
193.2500g/mol
Density
1.0130g/cm3
Appearence

MDMA, commonly known as Ecstasy, is typically encountered as a white or off-white crystalline powder. It is often pressed into colorful tablets with various shapes and logos, or it may be available in capsules.

Comment on solubility

Solubility of 1-(1,3-benzodioxol-5-yl)-N-methyl-propan-2-amine (C11H15NO2)

The solubility of 1-(1,3-benzodioxol-5-yl)-N-methyl-propan-2-amine in various solvents is an important aspect to understand, particularly in the context of its applications in chemistry and pharmacology. This compound, characterized by its unique structure, exhibits varying solubility profiles:

  • Water: The solubility in water is expected to be limited due to the hydrophobic nature of the aromatic benzodioxole group.
  • Organic Solvents: This compound tends to be more soluble in organic solvents such as ethanol, methanol, and chloroform, where the non-polar characteristics of the structure are better accommodated.
  • pH Influence: The solubility can also be impacted by the pH of the solution; in acidic environments, the amine group may become protonated, potentially increasing solubility due to the formation of charged species.

In conclusion, while 1-(1,3-benzodioxol-5-yl)-N-methyl-propan-2-amine demonstrates limited aqueous solubility, it finds a more favorable environment in organic solvents. Understanding these solubility characteristics is crucial for its effective utilization in various chemical processes and formulations.

Interesting facts

Interesting Facts about 1-(1,3-benzodioxol-5-yl)-N-methyl-propan-2-amine

1-(1,3-benzodioxol-5-yl)-N-methyl-propan-2-amine, often referred to in the scientific community for its structural and functional characteristics, holds a fascinating position in the realm of organic compounds.

Chemical Overview

  • Amine Compound: This compound contains an amine group, which is known for its ability to engage in hydrogen bonding, impacting its reactivity and interaction with biological systems.
  • Benzodioxole Moiety: The inclusion of a benzodioxole ring imparts unique electronic properties and is often associated with various psychoactive substances.
  • Applications: Compounds similar to this have been explored for their potential in medicinal chemistry, particularly in the design of pharmaceuticals targeting the central nervous system.

Scientific Significance

This compound is notable for its connection to the field of neurochemistry. Some key points of interest include:

  • Psychopharmacology: Compounds featuring benzodioxole structures have been studied for modulating neurotransmitter systems, which may affect mood and cognition.
  • Research Potential: As scientists strive to understand the interactions of such compounds on neural pathways, they could lead to breakthroughs in treatments for mental health disorders.
  • Synthetic Versatility: This compound is part of a class that includes various other synthetically accessible derivatives, providing a rich canvas for research.

Conclusion

In summary, 1-(1,3-benzodioxol-5-yl)-N-methyl-propan-2-amine serves as an intriguing example of how organic compounds can provide insights into both chemical innovation and therapeutic research. As the scientific community continues to explore such compounds, their impact on pharmacological development remains an exciting area of study!

Synonyms
MDMA
Ecstasy
3,4-methylenedioxymethamphetamine
Midomafetamine
42542-10-9
Methylenedioxymethamphetamine
DL-(3,4-Methylenedioxy)methamphetamine
N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE
(RS)-3,4-(methylenedioxy)methamphetamine
N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine
HSDB 6929
1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine
midomafetamina
CHEBI:1391
Molly
UNII-KE1SEN21RM
1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl-
KE1SEN21RM
Methylenedioxymetamphetamine
Methylenedioxymethamfetamine
(+-)-(3,4-Methylenedioxy)methamphetamine
MANDY
CCRIS 9277
3,4-methylenedioxymetamphetamine
DEA No. 7405
Mandy [Street Name]
Molly [Street Name]
XTC [Street Name]
Phenethylamine, N,alpha-dimethyl-3,4-methylenedioxy-
Midomafetamine [USAN]
3,4-Methylenedioxy-N,alpha-dimethyl-beta-phenylethylamine
(+-)-N-Methyl-3,4-(methylenedioxy)amphetamine
1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine
CHEMBL43048
(+/-)-(3,4-Methylenedioxy)methamphetamine
(+-)-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane
XTC
DTXSID90860791
Mandy (Street Name)
Molly (Street Name)
XTC (Street Name)
D,L-3,4-METHYLENEDIOXYMETHAMPHETAMINE
1,3-Benzodioxole-5-ethanamine, N,.alpha.-dimethyl-
METHYLENEDIOXYMETHAMFETAMINE (MART.)
METHYLENEDIOXYMETHAMFETAMINE [MART.]
NCGC00168266-02
midomafetaminum
(+)-3,4-methylenedioxymethamphetamine
MDMA (Ecstasy)
rac-3,4-Methylenedioxymethamphetamine-D5
Midomafetamine [WHO-DD]
Epitope ID:178091
MDMA [MI]
Midomafetamine (USAN/INN)
MIDOMAFETAMINE [INN]
(+/-)-3,4-METHYLENEDIOXYMETHAMPHETAMINE
SCHEMBL44210
Methylenedioxy Methamphetamine
DivK1c_000962
3,4-MDMA
GTPL4574
KBio1_000962
DTXCID70197310
NINDS_000962
LFA76543
RCA14289
BDBM50010588
PDSP1_001522
PDSP2_001506
3,4-methylenedioxy-n-methylamphetamine
AKOS006283463
DB01454
IDI1_000962
NCGC00168266-01
NS00010441
C07577
D11172
Q69488
(+/-)-N-Methyl-3,4-(methylenedioxy)amphetamine
N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE [HSDB]
[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](methyl)amine
PHENETHYLAMINE, N,.ALPHA.-DIMETHYL-3,4-METHYLENEDIOXY-
(RS)-1-(BENZO(D)(1,3)DIOXOL-5-YL)-N-METHYLPROPAN-2-AMINE
(+/-)-N,.ALPHA.-DIMETHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE
(+/-)-N-METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-AMINOPROPANE
rac-MDMA (rac-3,4-Methylenedioxymethamphetamine) 1.0 mg/ml in Methanol